Evidence map›Paper›PMID 25302576›Full record

ArticleBiochemistry2014

Interactions of "bora-penicilloates" with serine β-lactamases and DD-peptidases.

Liudmila Dzhekieva, S A Adediran, R F Pratt

Abstract read
In one paragraph

Article in Biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Will morphing boron-based inhibitors beat the β-lactamases?Current opinion in chemical biology · 2019
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liudmila DzhekievaDepartment of Chemistry, Wesleyan University , Lawn Avenue, Middletown, Connecticut 06459, United States.
S A Adediran
R F Pratt
Wesleyan University · US

Funding

BETA LACTAMASES AND DD PEPTIDASES--ACTIVE SITE CHEMISTRYR01AI017986 · NIAID · WESLEYAN UNIVERSITY · PI PRATT, REX F · 1985 to 2010
$3.0M
Beta-Lactamases and DD-Peptidases: Active Site ChemistryR56AI017986 · NIAID · WESLEYAN UNIVERSITY · PI PRATT, REX F · 2008 to 2008
$413k
NIAID NIH HHS AI-17986
6 · The paper itself

Abstract

Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describes the synthesis, determination of the inhibitory activity, and analysis of the results from two α-(2-thiazolidinyl) boronic acids that are closer analogues of particular tetrahedral intermediates involved in β-lactamase and DD-peptidase catalysis than those previously described. One of them, 2-[1-(dihydroxyboranyl)(2-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid, is a direct analogue of the deacylation tetrahedral intermediates of these enzymes. These compounds are micromolar inhibitors of class C β-lactamases but, very unexpectedly, not inhibitors of class A β-lactamases. We rationalize the latter result on the basis of a new mechanism of boronic acid inhibition of the class A enzymes. A stable inhibitory complex is not accessible because of the instability of an intermediate on its pathway of formation. The new boronic acids also do not inhibit bacterial DD-peptidases (penicillin-binding proteins). This result strongly supports a central feature of a previously proposed mechanism of action of β-lactam antibiotics, where deacylation of β-lactam-derived acyl-enzymes is not possible because of unfavorable steric interactions.

Indexed as

Drug DesignModels, MolecularAcylationAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesBiocatalysisBoronic AcidsCatalytic DomainIsoenzymesKineticsMembrane ProteinsMolecular ConformationPenicillanic AcidPenicillin-Binding ProteinsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesBoronic AcidsIsoenzymesMembrane ProteinsPenicillanic AcidPenicillin-Binding Proteinspenicilloic acidSerineSerine EndopeptidasesSerine Proteinase Inhibitors

Identifiers

PMID25302576
PMCPMC4204886
OpenAlexW1989678182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.